المصدر: A Phase II Study of AZD2171 in Adult Patients With Neurofibromatosis Type 1 and Extensive Plexiform and Paraspinal Neurofibromas

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00326872Test

المصدر: Wemann BC, Salzer WL, ArcecRJ, Blaney SM, Fox E, End D, Glesp A, Whcomb P, Palumbo JS, Pney A, Jayaprakash N, Zannos P, Bal FM. Phase trl and pharmacoket study of the farnesyltransferase hor tarn chdren wh refractory sol tumors or neurofromatos type and plexorm neurofromas. J Cl Oncol. 2006 Jan 20;24(3):507-16. do 10.1200/JCO.2005.03.8638.
Korf BR. Plexorm neurofromas. Am J Med Genet. 1999 Mar 26;89(1):31-7. do 10.1002/(s1096-8628(19990326)89:13.0.co;2-w.
Frdman JM. Neurofromatos 1: clal manestatns and dgnost crer. J Chd Neurol. 2002 Aug;17(8):548-54; dcussn 571-2, 646-51. do 10.1177/088307380201700802.
Phase I Trial of the Raf Kinase and Receptor Tyrosine Kinase Inhibitor Sorafenib (BAY 43-9006, Nexavar) in Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00727233Test

المصدر: Ferner RE. Neurofromatos 1 and neurofromatos 2: a twenty fst century perspecte. Lancet Neurol. 2007 Apr;6(4):340-51. do 10.1016/S1474-4422(07)70075-3.
Korf BR. Clal features and pathoblogy of neurofromatos 1. J Chd Neurol. 2002 Aug;17(8):573-7; dcussn 602-4, 646-51. do 10.1177/088307380201700806.
K A, Glesp A, DombE, Goodw A, Goodspeed W, Fox E, Bal FM, Wemann BC. Characterts of chdren enrolled treatment trls for NF1-related plexorm neurofromas. Neurology. 2009 Oct 20;73(16):1273-9. do 10.1212/WNL.0b013e3181bd1326.
Natural History Study and Longitudinal Assessment of Children, Adolescents, and Adults With Neurofibromatosis Type 1

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00924196Test

Other URLs: https://clinicalstudies.info.nih.gov/cgi/detail.cgi?B_2008-C-0079.htmlTest